News | October 28, 2013

Valve-In-Valve Implants Provide Option for People With Adult Congenital Heart Disease Without Open Heart Surgery

heart valve repair valve-in-valve melody transcatheter pulmonary houston

October 28, 2013 — A new valve recently approved by the U.S. Food and Drug Administration (FDA) now gives heart patients a new way to manage their disease without having to undergo open heart surgery.?
 
The Melody Transcatheter Pulmonary Valve, which is delivered through a catheter and requires only a small incision, is a new technique that is bringing new hope to these patients with congenital heart disease.
 
C. Huie Lin, M.D., Ph.D., adult congenital heart disease specialist, recently implanted the first Melody Valve at Methodist DeBakey Heart and Vascular Center, Houston, in a young man who had already had three open heart surgeries for congenital heart disease. ??“More than a million people live with adult congenital heart disease in the U.S., and we expect that number to grow by 5 percent each year,” Lin said. “I believe this new Melody Valve is a great new option for people who were no longer candidates for surgery.”
 
Lin said the Melody Valve helps patients who have already had an open heart surgery for congenital heart disease and have developed problems with the valve leaking or becoming blocked.??The valve, made for the right side of the heart, is designed to be implanted inside of the existing valve. Made from the internal jugular vein of a cow, the valve is sewn onto a stent and the stent is then put onto a balloon catheter. The catheter is then placed through the femoral vein and advanced to the pulmonary valve position. The balloon then expands and deploys the valve.??“Because it’s implanted inside of an existing valve, a new Melody valve can also be implanted in an existing Melody valve if it’s not working properly,” Lin said. “It’s a revolutionary technique.”
 
For more information: www.medtronic.com, www.houstonmethodist.org

Related Content

News | Heart Valve Technology

June 29, 2026 — Laplace Interventional recently announced that the U.S. Food and Drug Administration (FDA) has approved ...

Home July 02, 2026
Home
Feature | Heart Valve Technology | Kyle Hardner

Primary care providers (PCPs) stand on the front lines of diagnosing clinically significant valvular heart disease (VHD) ...

Home July 01, 2026
Home
News | Heart Valve Technology

June 29, 2026 — Konica Minolta, Inc. has announced that a research group has developed a simple and rapid technique for ...

Home June 29, 2026
Home
News | Heart Valve Technology

June 18, 2026 — Nyra Medical has been selected as the recipient of the 2026 Jon DeHaan Foundation Award for ...

Home June 19, 2026
Home
News | Heart Valve Technology

April 24, 2026 – A novel detection algorithm spotted moderate-to-severe aortic stenosis (AS) with a sensitivity of 90.5% ...

Home April 24, 2026
Home
News | Heart Valve Technology

April 21, 2026 — A new multicenter study published in The Annals of Thoracic Surgery finds that reoperative surgical ...

Home April 22, 2026
Home
News | Heart Valve Technology

Dec. 26, 2025 — Edwards Lifesciences has announced the company’s SAPIEN M3 mitral valve replacement system, a ...

Home December 24, 2025
Home
News | Heart Valve Technology

Nov. 17, 2025 — Royal Philips has introduced DeviceGuide, an AI-powered device tracking* solution that assists ...

Home November 17, 2025
Home
News | Heart Valve Technology | Cedars-Sinai Medical Center

Oct. 28, 2025 — People who underwent a minimally invasive procedure to have their heart’s aortic valve replaced had ...

Home October 29, 2025
Home
News | Heart Valve Technology

Aug. 28, 2025 — Medtronic plc has announced it received U.S. Food and Drug Administration (FDA) approval for the ...

Home August 29, 2025
Home
Subscribe Now